We have isolated a family of four vertebrate genes homologous to eyes absent (eya), a key regulator of ocular development in Drosophila. Here we present the detailed characterization of the EYA4 gene in human and mouse. EYA4 encodes a 640 amino acid protein containing a highly conserved C-terminal domain of 271 amino acids which in Drosophila eya is known to mediate developmentally important protein-protein interactions. Human EYA4 maps to 6q23 and mouse Eya4 maps to the predicted homology region near the centromere of chromosome 10. In the developing mouse embryo, Eya4 is expressed primarily in the craniofacial mesenchyme, the dermamyotome and the limb. On the basis of map position and expression pattern, EYA4 is a candidate for oculo-dento-digital (ODD) syndrome, but no EYA4 mutations were found in a panel of ODD patients.
INTRODUCTION
The eyes absent (eya) gene is a key regulator of Drosophila development. The original allele at this locus, called clift, results in defective head development and is an embryonic lethal. Subsequently, a series of viable alleles has been identified, allowing genetic dissection of eya function (1). These alleles show a variety of phenotypic effects including reduced or absent eyes and ocelli, abnormal brain morphology and sterility (2) . However, it is in the developing eye that eya has been studied most extensively and it is now clear that eya is a key regulator of ocular differentiation, playing an essential role in ensuring the ocular fate of the cells in the eye imaginal disc. The onset of ommatidial differentiation is marked by movement of the 'morphogenetic furrow' across the disc, which leaves in its wake clusters of maturing photoreceptors (3) . eya normally is expressed in cells immediately ahead of the furrow but in eya mutants these cells die instead of being recruited into the normal pathway of ocular development (1) . The discovery that ectopic eya expression can induce eye formation in non-eye imaginal discs-as was previously shown for eyeless (the Drosophila homologue of PAX6)-places eya near the top of the ocular regulatory hierarchy (4) . A total of four genes, eya, eyeless, sine oculis (so) and dachshund (dac), are now known which are capable of acting synergistically to impose an ocular fate on non-eye discs: these loci form a genetic 'cassette' which specifies eye development (5) (6) (7) (8) . The molecular basis of the complex relationship between these genes lies at least in part in direct physical interactions between the protein products of eya, dac and so (5, 6) . These findings immediately raise the exciting possibility that the molecular interactions of the Drosophila eye cassette may also be conserved in vertebrates, establishing a fundamental genetic link between the way in which developmental programmes are initiated and executed in widely diverged species.
As a starting point for the isolation of vertebrate homologues of eya, we searched the expressed sequence tag database (dbEST) for entries with homology to eya (9) and identified two distinct human ESTs. Based on a comparison of the sequence of the corresponding cDNA clones with Drosophila eya, we designed degenerate primers for cross-species RT-PCR from human, mouse and chick, which resulted in identification of a family of four different vertebrate eya-related cDNA sequences. These cDNAs, designated EYA1-4, all contain a large C-terminal domain with extensive homology to eya. Three of these vertebrate genes (EYA1-3) have been reported by others (10, 11) . Functional conservation of the EYA genes has been strikingly illustrated by *To whom correspondence should be addressed. Tel: +44 131 332 2471; Fax: +44 131 343 2620; Email: isabel.hanson@hgu.mrc.ac.uk + These authors contributed equally to this work Figure 1 . A family of four vertebrate cDNAs related to the eya gene of Drosophila. Alignment of conceptually translated cDNA sequences obtained by cross-species RT-PCR using degenerate primers against the highly conserved EYA-domain peptide motifs GGVDWM and YVVIGDG. h, human; m, mouse; ch, chick; f, Fugu; dm, Drosophila (1) . Identical residues are shown on a black background, and conservatively substituted residues are shaded. Two RT-PCR products were identified for human EYA4 which differ in nucleotide sequence at the 3′ end; these are derived from alternative splice forms using either exon 20 (h-eya4a) or exon 19 (h-eya4b; see text). The Fugu Eya4 (f-eya4) sequence was obtained with the same primers from genomic clones (see text). Alignments were created with the programs Pileup and Prettybox from the GCG package. The nucleotide sequences of the RT-PCR products have the following accession nos: human EYA2, AJ007992; human EYA3, AJ007991; human EYA4'a' (exon 20 splice form), AJ007993; human EYA4'b' (exon 19 splice form), AJ007994; mouse Eya1, AJ007995; mouse Eya3, AJ007996; mouse Eya4, AJ007997; chicken Eya1, AJ008002; chicken Eya3, AJ008003; chicken Eya4, AJ008004; the Fugu Eya4-like sequence is comprised of four genomic fragments, AJ007998-AJ008001.
the ability of mouse Eya3 to rescue the Drosophila eya phenotype (4), while in human development the importance of EYA genes is highlighted by the discovery that mutations in the EYA1 gene underlie two dominantly inherited syndromes, branchio-otorenal syndrome and branchio-oto syndrome (11) (12) (13) . Here we describe the detailed characterization of mouse and human EYA4. Based on map location and expression pattern, EYA4 was considered a strong candidate for human oculo-dento-digital syndrome (ODD) (14) . However, we were unable to find any EYA4 mutations in ODD patients despite a thorough search, and we conclude that ODD is not caused by general loss-of-function mutations in EYA4.
RESULTS

Isolation of vertebrate EYA genes
We began our search for vertebrate homologues of eya by exploiting the wealth of data generated by the EST sequencing project (9, 15) . By performing a simple text string search of dbEST, it was possible to identify sequences which had already been annotated as having significant homology to eya through routine screening of ESTs against known genes in the public databases. This initial stringsearch approach yielded two distinct human ESTs (accession nos H07988 and Z39529) which appeared to be derived from two separate human eya-related genes on the basis of nucleotide sequence. The corresponding cDNA clones (IMAGE IDs 45134 and 54132) were sequenced completely and found to have highly significant homology to the C-terminal region of eya. To identify any further members of the vertebrate gene family, we designed degenerate oligonucleotides against two peptide motifs GGVDWM and YVVIGDG which are separated by 119 amino acids and are conserved between the fly eya protein and the predicted product of IMAGE clone 45134. Degenerate RT-PCR products from human glioblastoma and lens cell lines, mouse embryos and chick embryos were cloned, and several dozen recombinants from each RNA source were sequenced. By combining the degenerate cross-species RT-PCR and EST searching approaches, and performing pairwise comparisons of the nucleotide and predicted amino acid sequences, we characterized a total of four distinct vertebrate eya-related cDNAs designated EYA1-4 ( Fig. 1) . We also hybridized a pufferfish cosmid library with the insert of IMAGE clone 45134 (human EYA2) and identified a subset of cosmids which amplified at the genomic level with the degenerate primers. When sequenced, the genomic PCR product was found to contain four eya-related exons. Pairwise comparisons of the predicted translation product of these exons with those of the RT-PCR clones revealed that these Fugu cosmids contained the putative pufferfish homologue of EYA4 (Fig. 1) .
The mouse and human genes EYA1-3 have been described in detail by others (10, 11) . We chose to focus on a new member of the family, EYA4.
Identification of mouse and human EYA4 cDNAs
A mouse 11 day embryo cDNA library was screened with a mouse Eya4 probe, MRT11, which was obtained by degenerate RT-PCR (Fig. 1, m-eya4) . Analysis of eight positive clones and 5′ RACE PCR products led to the definition of a 2699 bp contig (accession no. Y17115) containing a 2551 bp open reading frame (ORF). The first ATG is located 319 bp from the beginning of the sequence, while a TAA translation termination codon was present at nucleotide 2171, resulting in a predicted 617 amino acid polypeptide. BLASTN analysis of dbEST revealed the presence of ESTs corresponding to both the mouse (accession no. Nucleotide and predicted amino acid sequence of the human EYA4 gene (accession no. Y17114). In the nucleotide sequence, the first in-frame ATG is shown in bold and the three regions affected by alternative splicing are underlined. These correspond to exon 5, the first 68 nucleotides of exon 16, and exon 20. The cryptic splice acceptor in exon 16 consists of the last 14 nucleotides of the second underlined region. In the amino acid sequence, the highly conserved C-terminal 271-amino acid 'EYA domain' is shown in bold. The position of the stop codon is indicated with @. AA072879) and the human (accession no. AA176744) EYA4 transcripts.
Screening of a human skeletal muscle cDNA library using the IMAGE cDNA clone 611269 (corresponding to EST AA176744) yielded >100 positive clones out of 1 × 10 6 recombinant phage plated. Nucleotide sequence analysis of 10 overlapping cDNA clones allowed us to build the 3077 nucleotide consensus sequence shown in Figure 2 (accession no. Y17114). The human transcript contains a single 1920 bp ORF with the first in-frame ATG codon at nucleotide 442. This ATG partially fulfils the Kozak criteria for an initiation codon (16) and is preceded, 12 bp upstream, by an in-frame stop codon. A TAA stop codon is present at nucleotide 2359, giving a predicted protein product of 639 amino acids with an estimated mol. wt of 69.5 kDa. The 5′-and 3′-untranslated regions are 441 and 716 bp, respectively.
Both mouse and human transcripts correspond to a novel mammalian gene that we named EYA4, according to the Human Genome Organization (HUGO) Nomenclature Committee's recommendation.
Sequence analysis and homology with EYA genes
Comparison of human and mouse EYA4 nucleotide sequences revealed 79.7% identity for the entire cDNA sequence, a value that reaches 88.9% in the coding region, with an overall amino acid sequence identity of 90.9%. Interestingly, the human polypeptide has a stretch of 23 amino acids which is absent in the mouse protein (Fig. 3) . Human cDNA clones have also been isolated which encode a protein lacking these amino acids. Genomic analysis revealed that the 23 amino acid sequence is encoded by exon 5 in the human gene, indicating the presence of alternative splicing.
A BLAST comparison of the EYA4 protein with a nonredundant protein database revealed significant homology with all the members of the mammalian EYA family, with the Drosophila eya protein and with a predicted Caenorhabditis elegans polypeptide from a 2.2 Mb genomic sequence from chromosome III. The homology is particularly high in the 271 amino acid C-terminal 'EYA-domain' region which begins at residue 
Genomic mapping of EYA4 and Eya4
To determine the chromosomal assignment of the human EYA4 gene, we performed radiation hybrid (RH) analysis using the Genebridge 4 panel as described in Materials and Methods.
Linkage was detected, with a lod score >3, to previously mapped reference markers, allowing us to localize EYA4 between CHLC.GATA23B12 and AFMA074ZG9 on the MIT RH map of the long arm of chromosome 6 (data not shown). The chromosomal localization on 6q23 was confirmed independently by fluorescence in situ hybridization (FISH) analysis with a 2.1 kb XbaI genomic fragment containing exon 13 (data not shown).
Yeast artificial chromosome (YAC) clones (855_a_2, 958_g_10) corresponding to EYA4 were identified in the CEPH human Mega-YAC library by PCR-based screening with the primers RH1 and RH2. These YACs are part of the Whitehead Institute/MIT Center for Genome Research chromosome 6 integrated map.
The mouse Eya4 gene was genetically mapped on chromosome 10 between markers D10Xrf5 and Aco2 in a region that is homologous to human chromosome 6q22-q23 (Fig. 4) .
To test a possible involvement of this gene in human inherited disorders, we used the Online Mendelian Inheritance in Man (OMIM) database to retrieve information on the disease loci mapped to the same chromosomal region. Interestingly, EYA4 maps within the critical region for ODD syndrome (OMIM 164200) (14) .
Genomic structure
Hybridization of cDNA probes to both cosmid and phage P1-derived artificial chromosome (PAC) arrayed libraries led to the identification of genomic clones corresponding to the EYA4 gene. EcoRI cosmid fragments hybridizing to cDNA probes were subcloned in plasmid vectors and sequenced using oligonucleotide primers designed from the cDNA sequence. In addition, both cosmid and PAC clones were sequenced directly using EYA4 exon primers. Twenty-one exons were identified and the sequence of all exon-intron boundaries was determined. Exon sizes and splice junction sequences are shown in Table 1 .
Alternative splicing
The analysis of different EYA4 cDNA clones and RT-PCR products led to the identification of three alternatively spliced forms of the major transcript presented in Figure 2 . Form a is characterized by the absence of 70 nucleotides corresponding to exon 5 (Figs 2 and 5A) and is present in a number of cDNA clones identified from a human skeletal muscle cDNA library. Mouse cDNA clones derived from an 11 day embryo library also lack the sequence corresponding to human exon 5. Figure 3 appears to correspond to the form c splice variant. There is 95.2% identity between the amino acid sequences of the EYA-domains of Eya4 and the human EYA4 exon 20 isoform as shown in Figure 3 , but the identity increases to 99.3% when Eya4 is compared with the human EYA4 exon 19 isoform.
Expression pattern of Eya4
The tissue distribution of Eya4 expression was examined using northern blot analysis and RNA in situ hybridization to wholemount embryos and sections.
Hybridization of a cDNA probe from the 3′-untranslated region of mouse Eya4 to a northern blot with poly(A) + RNA from various adult tissues revealed that Eya4 is expressed in skeletal muscle (Fig. 6 ). These data are consistent with the fact that a large number of EYA4 cDNAs were isolated from a human skeletal muscle cDNA library, suggesting a similar pattern of expression in man. The size of the mouse transcript, 5.5 kb, is larger than that of our Eya4 cDNA contig, suggesting that some additional untranslated sequences are missing from our sequence.
To determine the expression pattern of Eya4 in the developing mouse embryo, we performed RNA in situ hybridization to whole-mount embryos and sections. At E9.5, Eya4 is expressed in the nasal placode, the otic vesicle and in two stripes flanking the dorsal midline above the developing forelimb bud (Fig. 7a  and b) . By E10.5, Eya4 is clearly expressed in the branchial arch region and in the vicinity of the somites (Fig. 7c) . At E11.5, Eya4 expression is detected in a broad stripe of craniofacial mesenchyme above the nasal process and between the eyes (Fig. 7d  and f) . There is also very strong expression in the region of the somites, which on vibratome sectioning was found to correspond to the dermamyotome (Fig. 7e) . At the level of the developing limbs, Eya4-positive cells appear to be migrating away from the dermamyotome into the limb structures in a pattern resembling that of migrating muscle precursor cells (17, 18) . At E12.5, the same craniofacial region is still positive (Fig. 8A and B) while in the limb, Eya4-expressing cells are now present in the condensing mesenchyme of the hand and foot plates, surrounding the pre-cartilage condensations of the digits in the region of the developing flexor tendons (Figs 7g and h and 8E and F). Eya4 expression is also detected in the developing urogenital system (Fig. 8D ) and in the tongue and jaw at E12.5 ( Fig. 8B and C) .
In summary, Eya4, like mouse Eya1-3 and Drosophila eya itself, is widely expressed during development (2,10). However, in contrast to these other genes, we found no evidence for expression of Eya4 in the developing eye at any of the stages examined. A major domain of Eya4 expression includes the dermamyotome and cells apparently migrating from it to populate the developing limbs. Although the dermamyotomal localization was only confirmed at E11.5, the expression pattern at E10.5 (band of expressing cells above the forelimb, Fig. 7c ) and E9.5 (parallel stripes of expression overlying the more rostral somites, Fig. 7b ) is consistent with a role for Eya4 in the maturation of limb muscle precursors. Like Eya4, Eya1 and Eya2 are expressed in the developing limb including the dermamyotome, migrating muscle precursors and tendons (19) .
Mutation analysis of EYA4 in ODD syndrome
The genomic map position of EYA4, together with the developmental expression pattern of Eya4 in the limb and the face, made EYA4 a promising candidate for ODD syndrome, a congenital disorder which shows autosomal dominant inheritance with high penetrance. Phenotypic expression is variable, but affected individuals often have a highly characteristic facial appearance with a thin nose, hypoplastic alae nasi (nasal wings) and anteverted nares (14) . Typical involvement of the eyes, teeth and limbs includes microcornea or microphthalmia, hypoplasia of the dental enamel and syndactyly of the fourth and fifth fingers (type III syndactyly). Linkage analysis of six affected families placed the ODD locus at 6q22-q24 in an interval flanked by D6S474 and D6S292 (14) ; EYA4 lies within this critical region. Our patient panel consisted of four of the 6q-linked families previously reported, one individual from a two-generation family and three sporadic cases, thus giving a maximum possible total of eight different ODD alleles. We used a variety of approaches to search for mutations in the 21 exons of EYA4. Individual exons were amplified from genomic DNA and screened for sequence variants by single strand conformation polymorphism (SSCP), heteroduplex analysis and dideoxy fingerprinting. In addition, five of the exons (1, 2, 3, 7 and 19) were sequenced directly in seven of the eight ODD alleles. Southern blot analysis of patient DNA using three different EYA4 probes covering both coding and non-coding regions failed to detect any altered hybridization pattern with respect to normal controls. Lymphoblastoid cell lines (LCL) were available from seven patients, three of which were from the 6q-linked family ODD 1 and one of which was from the 6q-linked family ODD 2 (14) . LCL chromosomes were subjected to standard karyotypic analysis and in all cases were found to be normal. Chromosomal FISH analysis with a cosmid (Cos4) containing the 3′ end of EYA4 was normal, with two strong signals detected on 6q in each case. In addition, LCL RNA was analysed by nested RT-PCR for splice mutations in the EYA-domain of EYA4. No difference was seen between patients and normal Eya4 is expressed in the craniofacial mesenchyme (cfm) above the nose and between the eyes, the future external auditory meatus (eam), the dermamyotome (dm), the forelimb and the hindlimb. Strong expression was also seen in a domain linking the dermamyotome with the limb (arrowhead). (e) Transverse vibratome section of an E11.5 whole-mount embryo at the level of the forelimb. Eya4 is expressed strongly in the dermamyotomal compartment of the somites but not in the neural tube (nt) or dorsal root ganglia (drg). Eya4 is also expressed in streams of cells which appear to be moving from the dermamyotome into the forelimb. (f) Transverse vibratome section through the head of an E11.5 whole-mount embryo. Eya4 expression is clearly visible in the craniofacial mesenchyme overlying the olfactory epithelium (oe). The eye, including the lens (l), is negative. (g) Whole-mount hybridization of hindlimb plate (left) and forelimb plate (right) at E12.5. Eya4 is expressed in the vicinity of the condensing digits. (h) A section through a whole-mount-hybridized forelimb showing that Eya4 is expressed around but not within the pre-cartilage condensations (pcc) of the individual digits.
individuals. Given the size of our patient panel and the variety of analyses performed, we conclude that ODD is not caused by general loss-of-function mutations of EYA4, although we cannot completely rule out the possibility that ODD is caused by a specific EYA4 mutation which we have been unable to detect.
DISCUSSION
We set out to isolate vertebrate homologues of the Drosophila eya gene. As a starting point, we screened dbEST, then complemented this with cross-species degenerate RT-PCR and cDNA library screening to define four vertebrate EYA genes. We have presented the detailed characterization of EYA4, a novel member of the family, in mouse and man. EYA4 is most closely related to EYA1, but has a distinct map location and developmental expression pattern.
Like EYA1-3, the EYA4 protein contains a C-terminal 271 amino acid domain with extensive homology to Drosophila eya. Although the function of this EYA-domain is unknown at present, it recently has been shown that the eya protein plays a key role in Drosophila ocular development by tethering the DNA-binding function of so protein to the trans-activation function of dac protein under the control of eyeless (PAX6) (5, 6, 8) . The protein-protein interactions eya-so and eya-dac form the molecular basis of a developmental 'cassette' in which a unique combination of gene products imposes a specific fate on a group of cells (7). These findings immediately raise the question of whether such regulatory cassettes are a general phenomenon, essential for the successful execution of specific developmental programmes, and whether they exist in vertebrates. Given that all the genes of the eye cassette have vertebrate homologues (20, 21) it seems highly likely that the same molecular interactions will be conserved, although it is intriguing to note that the potential combinations are numerous given that there are four known homologues of eya (EYA genes) and five known homologues of so (SIX genes). In Drosophila, all the genes of the eye cassette are expressed separately elsewhere in non-ocular tissue; thus it is the specific combination of gene activity that is crucial, so that in theory a very small number of 'successful' proteins can be deployed in different combinations with different partners to induce specific tissue identities. In this respect, it is interesting to note that the expression pattern of Eya4 in the dermamyotome and in cells emerging from the dermamyotome to populate the limb is remarkably similar to that of Six1, a mouse homologue of Drosophila so (22) , and also overlaps extensively with Pax3 (17) and with Eya1 and Eya2 (19) . The complex expression pattern of Pax3, Six1, Six2, Eya1, Eya2 and Eya4 in the precursors of the limb musculature and connective tissue may play a role in ensuring that these migrating cells remain committed to their fate until they reach their destination, and could clearly involve co-expression of PAX, EYA and SIX proteins at the cellular level (18, 19, 22) . Given that Six1 and Six2 are expressed from E8.2 and E8.5, respectively, it will be of interest to examine the expression pattern of Eya4 at these earlier stages (22) .
Alternatively spliced transcripts have been observed in the Drosophila eya gene (1,2) and in human EYA1 (12) . In both cases, the splice variants are restricted to the 5′ end of the gene and create isoforms with alternative ATG start codons. Three alternatively spliced EYA4 transcripts have been identified and it is notable that two of these affect the highly conserved C-terminal domain (Fig.  5) . Form b results in a frameshift leading to the generation of a truncated protein, while form c results in the substitution of 11 amino acids. It will be of interest to determine whether the form c alternative splice, in which exon 20 is replaced by exon 19, involves the unusually short intron (just 38 bp) separating the two exons. The relative abundance and functional relevance of all the alternative splice forms remain to be investigated.
On the basis of the mouse embryonic expression pattern (in particular in the face and the limb) and human map location, EYA4 was considered to be a good candidate for ODD syndrome. We used a variety of approaches to look for mutations and rearrangements of EYA4 in a panel of ODD patients, including individuals from families which show linkage to 6q. No mutations were found, and we conclude that ODD is not caused by general loss-offunction mutations in EYA4. Perhaps significantly in view of the frequent eye involvement of ODD patients, we did not detect ocular expression of mouse Eya4 at the developmental stages examined even though we identified several EYA4 clones amongst the RT-PCR products from human lens cell lines. We could not rule out the possibility that human EYA4 is expressed in the embryonic eye or that mouse Eya4 is transiently expressed but not observed by us. In summary, we consider it very unlikely that EYA4 is the ODD gene, although it remains a candidate for developmental syndromes which map to 6q23.
MATERIALS AND METHODS
EST database searching
The initial search was performed with a text screen of dbEST as previously described (9) . Two distinct human ESTs were identified: GenBank accession nos H07988, from IMAGE clone 45134, and Z39529, from IMAGE clone 54132. The IMAGE cDNA clones were obtained from Research Genetics (USA) and the MRC HGMP Resource Centre (Hinxton, Cambridgeshire, UK). The sequence of each cDNA clone was determined by automated sequencing. IMAGE clone 45134 is derived from human EYA2 and is present in the nucleotide sequence databases as DRES12 (accession no. U69178); IMAGE clone 54132 is derived from human EYA3 and is contained entirely within the previously published EYA3 sequence (11).
Degenerate RT-PCR
Based on the nucleotide sequence of human IMAGE clone 45134, two peptide motifs were identified (GGVDWM and YVVIGDG) which are conserved between Drosophila and human, and show relatively low codon redundancy, thus facilitating the design of degenerate primers. The forward primer (GGVDWM motif, nucleotides 1875-1858 in Fig. 2 ) was 5′-GGN GGN GTN GA(TC) TGG ATG-3′ and the two reverse primers (YVVIGDG motif, complement of nucleotides 2233-2252 in Fig. 2 ) were 5′-CCA TCN CC(TGA) ATN ACN ACA TA-3′ and 5′-CCA TCN CC(TGA) ATN ACN ACG TA-3′, where N is any nucleotide. For each RNA source, first strand cDNA was amplified in two separate PCRs containing the forward primer with each of the two reverse primers to avoid excessive degeneracy.
Total RNA was isolated from human glioblastoma cell lines, human lens epithelial cell lines, 12.5 day mouse embryos, 3.5 day chick embryos and 5.5 day chick embryo heads using total RNA isolation reagent (Advanced Biotechnologies). One microgram of total RNA was reverse transcribed in a volume of 20 µl with 25 U AMV reverse transcriptase (Boehringer Mannheim) using the supplied buffer in the presence of 50 pmol of random hexamers (Pharmacia), 1 mM dNTPs and 40 U RNase inhibitor (Boehringer Mannheim). Reverse transcription was carried out at 42_C for 1 h followed by 8 min at 75_C. For the amplification step, the reverse transcription reaction was diluted into 100 µl containing 1 µM of each degenerate oligo, 1× PCR buffer (Cetus) and 2 U Amplitaq (Cetus). PCR conditions were: step 1 (94_C for 30 s) ×1 cycle; step 2 (94_C for 30 s, 52_C for 45 s, 72_C for 30 s) ×30 cycles; step 3 (72_C for 10 min) ×1 cycle. At step 2, there was a ramp of 3_C/s between the annealing temperature (52_C) and the extension temperature (72_C). PCR products were blunt-ended with Klenow, kinased and ligated to EcoRI linkers (New England Biolabs) before cutting with EcoRI and ligating into EcoRI-cut, alkaline phosphatase-treated pBluescript SK+ (Stratagene). The recombinants from each RT-PCR reaction were screened by hybridization with the insert of IMAGE clone 45134, and at least 24 positive clones were sequenced in each case.
Isolation of Fugu genomic EYA clones
A gridded Fugu rubripes genomic cosmid library was obtained from the HGMP Resource Centre and screened by hybridization with the insert of IMAGE clone 45134. Positive clones were obtained from HGMP and used as templates for PCR amplification with the degenerate primers. Four cosmids (032C09, 096P07, 107H09 and 198L17) gave an identical 1.2 kb genomic PCR product which was cloned and sequenced to reveal the presence of exons related to the EYA4 subfamily (f-eya4 in Fig. 1 ).
cDNA and genomic library screening
Phage library plating and screening conditions were as previously described (23) . Human cDNA clones were isolated from a human adult skeletal muscle cDNA library (Clontech HL5002a) in Lambda GT10 vector. Mouse cDNA clones were isolated from a mouse 11 day embryo cDNA library (Clontech ML3003a) in Lambda GT10 vector. Recombinant phage recognized by the probes were isolated and the insert was recovered by EcoRI digestion and subcloned in pBluescript II SK-(Stratagene).
Both cosmid (Lawrence Livermore National Laboratory chromosome 6 arrayed cosmid library) and PAC (RPCI-5) human genomic clones were isolated by hybridization with various EYA4 cDNA probes.
DNA sequencing
Both manual (using a Sequenase Version 2.0 7-deaza-dGTP DNA sequencing kit from USB) and automated (using an Applied Biosystems ABI 377 fluorescent sequencer) sequencing were performed using vector-and gene-specific oligonucleotide primers. The nucleotide sequences of the human and the mouse EYA4 cDNAs have been submitted to the databases under accession nos Y17114 (human) and Y17115 (mouse).
Computer sequence analysis
Sequence assembly and editing was performed using both the AutoAssembler version 1.4 (Applied Biosystems, Perkin Elmer) and DNA Strider 1.2 programs (24). Multiple sequence alignment was performed using the Clustal W algorithm (25) and Pileup [Wisconsin Package Version 9.1; Genetics Computer Group (GCG), Madison, WI]. Nucleotide and amino acid sequences were compared with the non-redundant sequence databases present at the National Center for Biotechnology Information (NCBI) using version 2.0 of BLAST (26) . The global alignment program (GCG) was used to analyse identity and similarity among different nucleotide and amino acid sequences.
FISH mapping
FISH was performed on chromosome preparations obtained from lymphocyte metaphases from a 46,XY subject after 5-bromodeoxyuridine synchronization and thymidine release, with a 1 h colchicine block. A 2.1 kb EYA4 XbaI genomic probe, labelled with biotin-16-dUTP by nick translation (Boehringer Mannheim), was hybridized to chromosome preparations previously denatured at 70_C in 70% formamide/2× SSC. Hybridization mixture (30 µl/slide) contained the biotinylated probe (200 ng/slide) plus salmon sperm DNA (1 µg/slide) and Cot-1 DNA (10 µg/slide). After overnight hybridization (37_C), slides were washed at 37_C in 50% formamide/2× SSC (3×5 min) and in 2× SSC (3×5 min). Detection was performed by incubation of the slides with fluorescein isothiocyanate-avidin, according to the Oncor detection kit protocol with two amplification steps. Propidium iodide-counterstained slides were banded with 4′,6-diamidino-2-phenylindole (DAPI) and mounted in antifade solution (Vectashield mounting medium; Vector). Only those chromosomes with signals present on both chromatids at the same band position were taken into consideration.
Radiation hybrid mapping
For RH mapping, we used the Genebridge 4 panel (Research Genetics, Huntsville) which contains 93 human/hamster clones. The EYA4 PCR primers were RH1 (5′-CAA GAT GAT CTC TAG GAA GGG AGA C-3′; located in the intron preceding exon 13) and RH2 (5′-ATA AGA CCC GGT GAG CAG TGA GTG-3′; located in exon 13, complement of nucleotides 1591-1614 in Fig. 2) . These primers amplify a 163 bp product from human genomic DNA and give no specific amplification from hamster genomic DNA. DNA (25 ng) for each of the 93 hybrid clones, plus human and hamster genomic DNA controls, were used for PCR amplification in 96-well microtitre plates. Thirty-five cycles of amplification were performed (initial denaturation at 94_C for 2 min, followed by 94_C for 45 s, 60_C for 45 s and 72_C for 45 s). The result of PCR analysis was sent to the Radiation Hybrid Mapper server at the Whitehead Institute/MIT Center for Genome Research (http://www-genome.wi.mit.edu/cgi-bin/ contig/rhmapper.pl ). This server returns an MIT framework marker linked to the subject STS with a LOD score >3.0.
Linkage mapping of Eya4 in mouse
Genetic mapping was achieved utilizing a (C57BL/6j×SPR-ET/Ei)F 1 × SPRET/Ei (BSS) backcross generated and distributed by the Jackson Laboratory (Bar Harbor, ME) (27) . A TaqI restriction fragment length polymorphism (RFLP) was identified by hybridization of C57BL/6j and SPRET/Ei parental DNAs cut with each of the six restriction enzymes (EcoRI, EcoRV, KpnI, MspI, TaqI and XbaI). Four Southern panels containing MspI-cut parental DNAs and N 2 progeny DNAs (n = 94) were hybridized with an Eya4 cDNA probe (clone 10.2). The resulting strain distribution pattern (SDP) was analysed with the Map Manager 2.6 program (28).
Expression studies
A northern blot of poly(A) + RNA from various mouse adult tissues was purchased from Clontech and hybridized using standard protocols (23) .
RT-PCR experiments were carried out according to the manufacturer's recommended conditions (Gibco BRL and Boehringer Mannheim) (29) . To investigate alternative splicing of EYA4, primers M4 (5′-CTC CAC ACC CAT CAA AGA TC-3′; nucleotides 1437-1456 in Fig. 2 ) and L868 (5′-TAA ATA TTC TCA ATG GGG AAA G-3′; complement of nucleotides 2141-2162 in Fig. 2 ) were used to amplify first strand cDNA from human lymphoblastoid and lens cell lines; a nested PCR was then performed using oligonucleotides M145 (5′-ACC TGT AGG AGT TCT GGG TCA-3′; nucleotides 1468-1488 in Fig. 2 ) and L722 (5′-CTA TAG AGT AGA ACC TTC GC-3′; complement of nucleotides 2110-2129 in Fig. 2 ). Agarose gel electrophoresis revealed the presence of a product of the expected size (662 bp) and a smaller product (∼600 bp), which were sequenced directly as previously described (29) .
Adult heart and skeletal muscle human cDNAs were amplified by RT-PCR using oligonucleotide primers 2F (5′-CTG ACA GAT TCC TGG CTA AC-3′; nucleotides 2002-2021 in Fig. 2 ) and 17R (5′-GTT TAA CTC CAT TCA GCA ATC-3′; complement of nucleotides 2508-2528 in Fig. 2) . The resulting amplification products were analysed with restriction enzymes, subcloned into pBluescript vector and sequenced.
Digoxigenin-labelled sense and antisense riboprobes for use in whole-mount in situ hybridization were prepared from the mouse Eya4 RT-PCR clone MRT11 (Fig. 1, m-eya4) .
Hybridization to E9.5, E10.5, E11.5 and E12.5 mouse embryos was carried out as described previously (21) .
Mouse embryo sectioning and radioactive in situ hybridization were performed as described (30) . Embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline and embedded in paraffin. Sets of serial sections were hybridized with [ 35 S]UTPlabelled antisense or sense riboprobes. A 900 bp mouse Eya4 cDNA clone in pBluescript KS-was linearized with an appropriate restriction enzyme in order to transcribe either sense or antisense 35 S-labelled riboprobes, using the Stratagene RNA transcription kit. Slides were exposed for 2-3 weeks. Sections were counterstained in Hoechst 33258 dye to stain the cell nuclei. The red colour represents the hybridization signal (Fig. 8) .
ODD patient cohort
The ODD patient panel included individuals from the 6q-linked families ODD 1, ODD 2, ODD 4 and ODD 5 described by Gladwin et al. (14) . Two affected members of each of these families were analysed, except for pedigree ODD 4 where all members were examined. In addition, we analysed one affected individual from a two-generation family, and three separate sporadic cases. LCL were available from three members of family ODD 1, one member of family ODD 2, one member of the two-generation family and all three sporadic cases.
Mutation analysis
Individual exons of the EYA4 gene were amplified from genomic DNA under standard PCR conditions using primers located within the flanking introns (sequences available on request). SSCP analysis (31) was performed on 6% polyacrylamide gels (29:1 acrylamide:bis-acrylamide) with PCR fragments internally labelled by incorporating 0.1 µl of [α-32 P]dCTP (3000 Ci/mmol). Combined SSCP and heteroduplex analysis was carried out as previously described (32) .
Southern blot analysis
Southern blot analysis was performed on 7 µg of genomic DNA using standard protocols (23) .
